Steven Vitale

Steven Vitale has extensive experience in various roles related to business development, marketing, and management.

Since 2022, they have been working as the Vice President of Business Development at Prognos Health, where they are responsible for integrating and analyzing patient-centric data sources to provide clinical insights for strategic decision-making.

Prior to that, from 2021 to 2022, they held the same position at Syapse, focusing on business development efforts.

From 2017 to 2021, they worked at Diaceutics PLC, first as the Executive Vice President of Sales & Marketing, driving growth and supporting a successful IPO. Later, they served as the Managing Director of Marketing, leading the planning and execution of marketing strategies.

Before joining Diaceutics PLC, Steven Vitale worked at Diaceutics Group as the Managing Director from 2015 to 2017. In this role, they facilitated the integration of therapies and diagnostics into the treatment pathway.

From 2011 to 2015, they held the position of Director, Management Advisor at TGaS Advisors, where they developed the Global Marketing Solution benchmark offering.

Earlier in their career, Steven Vitale worked at GlaxoSmithKline in various roles, including Innovation Director, US Vaccines; Director, Vaccines Marketing; Director, Vaccines Commercial Development; Director, Global Commercial Strategy, Cardiovascular/Metabolic; Product Manager, Metabolic New Business; Associate Product Manager, Paxil; and Management Development Associate.

Steven started their career in the insurance industry, working as an Excess Casualty Underwriter at Zurich American Insurance from 1995 to 1997, and as an Excess & Surplus Lines Underwriter at General Star Management Co. from 1993 to 1995.

Steven Vitale earned a Bachelor of Arts degree in Political Science from Amherst College, where they studied from 1987 to 1991. Steven later pursued a Master of Business Administration degree with a focus on Marketing at Carnegie Mellon University - Tepper School of Business from 1997 to 1999.